Krause, S. W., Rothe, G., Gnad, M., Reichle, A. und Andreesen, Reinhard
(2003)
Blood leukocyte subsets and cytokine profile after autologous peripheral blood stem cell transplantation.
Annals of hematology 82 (10), S. 628-36.
Im Publikationsserver gibt es leider keinen Volltext zu diesem Eintrag.
Zum PubMed-Eintrag dieses Artikels
Zum Artikel beim Verlag (über DOI)
Zusammenfassung
High-dose chemotherapy with autologous peripheral blood stem cell transplantation (PBSCT) includes the risk of infectious complications due to neutropenia and therapy-induced immune deviation. In order to understand early immune recovery in this situation, we analyzed the distribution of cell subsets by flow cytometry and we measured cytokine production in a whole blood assay stimulated with ...
Zusammenfassung
High-dose chemotherapy with autologous peripheral blood stem cell transplantation (PBSCT) includes the risk of infectious complications due to neutropenia and therapy-induced immune deviation. In order to understand early immune recovery in this situation, we analyzed the distribution of cell subsets by flow cytometry and we measured cytokine production in a whole blood assay stimulated with lipopolysaccharide (LPS) in order to induce monocyte (MO) activation in 43 patients with solid tumors or lymphoma treated with two cycles of high-dose chemotherapy and PBSCT. Blood was collected at the following time points: before start of mobilization chemotherapy, before and after high-dose chemotherapy, and 10 and 30 days after PBSCT. In the lymphocyte compartment, we found a depletion of B cells and naive T cells and a transitory reduction of natural killer (NK) cells, whereas MO and neutrophils recovered rapidly. However, during early recovery, HLA-DR expression on MO and the percentage of CD16(+) MO was considerably reduced. Production of proinflammatory cytokines interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF)-alpha upon LPS stimulation was severely impaired directly after chemotherapy and unexpectedly remained low during early recovery of myeloid cells, whereas production of IL-1RA was enhanced, indicating a shift of immune competent cells to an anti-inflammatory or anergic state early after PBSCT.
Bibliographische Daten exportieren
| Dokumentenart: | Artikel |
|---|
| Datum: | 2003 |
|---|
| Institutionen: | Medizin > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) |
|---|
| Identifikationsnummer: | | Wert | Typ |
|---|
| 12961030 | PubMed-ID | | 10.1007/s00277-003-0716-z | DOI |
|
|---|
| Klassifikation: | | Notation | Art |
|---|
| Antineoplastic Combined Chemotherapy Protocols/therapeutic use | MESH | | Cytokines/immunology | MESH | | Female | MESH | | Flow Cytometry | MESH | | Hematopoietic Stem Cell Transplantation/methods | MESH | | Humans | MESH | | Immunophenotyping | MESH | | Lipopolysaccharides/pharmacology | MESH | | Lymphocyte Subsets/immunology | MESH | | Male | MESH | | Monocytes/immunology | MESH | | Neutrophil Activation/immunology | MESH | | Transplantation Conditioning | MESH | | Transplantation, Autologous | MESH |
|
|---|
| Dewey-Dezimal-Klassifikation: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin |
|---|
| Status: | Veröffentlicht |
|---|
| Begutachtet: | Ja, diese Version wurde begutachtet |
|---|
| An der Universität Regensburg entstanden: | Ja |
|---|
| Eingebracht am: | 20 Apr 2010 05:50 |
|---|
| Zuletzt geändert: | 08 Mrz 2017 08:26 |
|---|
| Dokumenten-ID: | 14416 |
|---|
Alternative Metrik